nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Ear pain—Salbutamol—chronic obstructive pulmonary disease	0.00586	0.00586	CcSEcCtD
Nafarelin—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00565	0.00565	CcSEcCtD
Nafarelin—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00555	0.00555	CcSEcCtD
Nafarelin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00535	0.00535	CcSEcCtD
Nafarelin—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00532	0.00532	CcSEcCtD
Nafarelin—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.0053	0.0053	CcSEcCtD
Nafarelin—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.00494	0.00494	CcSEcCtD
Nafarelin—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.00492	0.00492	CcSEcCtD
Nafarelin—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00485	0.00485	CcSEcCtD
Nafarelin—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00485	0.00485	CcSEcCtD
Nafarelin—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00477	0.00477	CcSEcCtD
Nafarelin—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00474	0.00474	CcSEcCtD
Nafarelin—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.00474	0.00474	CcSEcCtD
Nafarelin—Acne—Prednisolone—chronic obstructive pulmonary disease	0.0047	0.0047	CcSEcCtD
Nafarelin—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Nafarelin—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Nafarelin—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Nafarelin—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00455	0.00455	CcSEcCtD
Nafarelin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00446	0.00446	CcSEcCtD
Nafarelin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00439	0.00439	CcSEcCtD
Nafarelin—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00435	0.00435	CcSEcCtD
Nafarelin—Herpes simplex—Prednisolone—chronic obstructive pulmonary disease	0.00429	0.00429	CcSEcCtD
Nafarelin—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00425	0.00425	CcSEcCtD
Nafarelin—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00421	0.00421	CcSEcCtD
Nafarelin—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Nafarelin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Nafarelin—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Nafarelin—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Nafarelin—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Nafarelin—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00402	0.00402	CcSEcCtD
Nafarelin—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Nafarelin—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Nafarelin—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00398	0.00398	CcSEcCtD
Nafarelin—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Nafarelin—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00397	0.00397	CcSEcCtD
Nafarelin—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.00395	CcSEcCtD
Nafarelin—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00389	0.00389	CcSEcCtD
Nafarelin—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00383	0.00383	CcSEcCtD
Nafarelin—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00383	0.00383	CcSEcCtD
Nafarelin—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Nafarelin—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Nafarelin—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00375	0.00375	CcSEcCtD
Nafarelin—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Nafarelin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00368	0.00368	CcSEcCtD
Nafarelin—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Nafarelin—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00367	0.00367	CcSEcCtD
Nafarelin—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Nafarelin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00363	0.00363	CcSEcCtD
Nafarelin—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00362	0.00362	CcSEcCtD
Nafarelin—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.0036	0.0036	CcSEcCtD
Nafarelin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Nafarelin—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00349	0.00349	CcSEcCtD
Nafarelin—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00347	0.00347	CcSEcCtD
Nafarelin—Acne—Prednisone—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Nafarelin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Nafarelin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nafarelin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nafarelin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nafarelin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Nafarelin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00326	0.00326	CcSEcCtD
Nafarelin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00326	0.00326	CcSEcCtD
Nafarelin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Nafarelin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Nafarelin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Nafarelin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Nafarelin—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Nafarelin—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Nafarelin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Nafarelin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Nafarelin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Nafarelin—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00314	0.00314	CcSEcCtD
Nafarelin—Tension—Formoterol—chronic obstructive pulmonary disease	0.00313	0.00313	CcSEcCtD
Nafarelin—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00313	0.00313	CcSEcCtD
Nafarelin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Nafarelin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Nafarelin—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Nafarelin—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Nafarelin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00309	0.00309	CcSEcCtD
Nafarelin—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Nafarelin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Nafarelin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Nafarelin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00301	CcSEcCtD
Nafarelin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00297	0.00297	CcSEcCtD
Nafarelin—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00296	0.00296	CcSEcCtD
Nafarelin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00294	0.00294	CcSEcCtD
Nafarelin—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Nafarelin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Nafarelin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0029	0.0029	CcSEcCtD
Nafarelin—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Nafarelin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Nafarelin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Nafarelin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Nafarelin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00276	0.00276	CcSEcCtD
Nafarelin—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Nafarelin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00271	0.00271	CcSEcCtD
Nafarelin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00271	CcSEcCtD
Nafarelin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00266	CcSEcCtD
Nafarelin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00266	0.00266	CcSEcCtD
Nafarelin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00266	0.00266	CcSEcCtD
Nafarelin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00263	0.00263	CcSEcCtD
Nafarelin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0026	0.0026	CcSEcCtD
Nafarelin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0026	0.0026	CcSEcCtD
Nafarelin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Nafarelin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Nafarelin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Nafarelin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.00256	CcSEcCtD
Nafarelin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Nafarelin—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00253	0.00253	CcSEcCtD
Nafarelin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.0025	0.0025	CcSEcCtD
Nafarelin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00246	CcSEcCtD
Nafarelin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Nafarelin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00242	CcSEcCtD
Nafarelin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00241	0.00241	CcSEcCtD
Nafarelin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00238	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00237	0.00237	CcSEcCtD
Nafarelin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Nafarelin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00235	CcSEcCtD
Nafarelin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00234	CcSEcCtD
Nafarelin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00234	0.00234	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Nafarelin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Nafarelin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00232	CcSEcCtD
Nafarelin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Nafarelin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Nafarelin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Nafarelin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00226	0.00226	CcSEcCtD
Nafarelin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00226	0.00226	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Nafarelin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Nafarelin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00223	CcSEcCtD
Nafarelin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Nafarelin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00222	0.00222	CcSEcCtD
Nafarelin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00221	CcSEcCtD
Nafarelin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00219	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Nafarelin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00217	0.00217	CcSEcCtD
Nafarelin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Nafarelin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Nafarelin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Nafarelin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Nafarelin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Nafarelin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00213	0.00213	CcSEcCtD
Nafarelin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.0021	CcSEcCtD
Nafarelin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Nafarelin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Nafarelin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Nafarelin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Nafarelin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Nafarelin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Nafarelin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Nafarelin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00203	0.00203	CcSEcCtD
Nafarelin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Nafarelin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00197	0.00197	CcSEcCtD
Nafarelin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Nafarelin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00192	CcSEcCtD
Nafarelin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00191	0.00191	CcSEcCtD
Nafarelin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00187	CcSEcCtD
Nafarelin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00187	CcSEcCtD
Nafarelin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Nafarelin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Nafarelin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00181	0.00181	CcSEcCtD
Nafarelin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.0018	0.0018	CcSEcCtD
Nafarelin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Nafarelin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Nafarelin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00176	CcSEcCtD
Nafarelin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00175	0.00175	CcSEcCtD
Nafarelin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00174	CcSEcCtD
Nafarelin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.00174	CcSEcCtD
Nafarelin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Nafarelin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00172	CcSEcCtD
Nafarelin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00169	CcSEcCtD
Nafarelin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00168	CcSEcCtD
Nafarelin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00165	CcSEcCtD
Nafarelin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00165	CcSEcCtD
Nafarelin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Nafarelin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Nafarelin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Nafarelin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Nafarelin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00164	0.00164	CcSEcCtD
Nafarelin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Nafarelin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Nafarelin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00163	CcSEcCtD
Nafarelin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00162	CcSEcCtD
Nafarelin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Nafarelin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Nafarelin—Depression—Prednisone—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Nafarelin—Headache—Montelukast—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00158	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00157	CcSEcCtD
Nafarelin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00156	CcSEcCtD
Nafarelin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Nafarelin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Nafarelin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Nafarelin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Nafarelin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00155	CcSEcCtD
Nafarelin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Nafarelin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00151	CcSEcCtD
Nafarelin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Nafarelin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00146	CcSEcCtD
Nafarelin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Nafarelin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00139	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Nafarelin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Nafarelin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Nafarelin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Nafarelin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Nafarelin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Nafarelin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Nafarelin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Nafarelin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Nafarelin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Nafarelin—Shock—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00099	0.00099	CcSEcCtD
Nafarelin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000976	0.000976	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000933	0.000933	CcSEcCtD
Nafarelin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000932	0.000932	CcSEcCtD
Nafarelin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000926	0.000926	CcSEcCtD
Nafarelin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00092	0.00092	CcSEcCtD
Nafarelin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00089	0.00089	CcSEcCtD
Nafarelin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000889	0.000889	CcSEcCtD
Nafarelin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000888	0.000888	CcSEcCtD
Nafarelin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000883	0.000883	CcSEcCtD
Nafarelin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000876	0.000876	CcSEcCtD
Nafarelin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000837	0.000837	CcSEcCtD
Nafarelin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000814	0.000814	CcSEcCtD
Nafarelin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000735	0.000735	CcSEcCtD
Nafarelin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000725	0.000725	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000701	0.000701	CcSEcCtD
Nafarelin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000677	0.000677	CcSEcCtD
Nafarelin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000651	0.000651	CcSEcCtD
Nafarelin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000646	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000645	0.000645	CcSEcCtD
Nafarelin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000642	0.000642	CcSEcCtD
Nafarelin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000608	0.000608	CcSEcCtD
